Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04883749
Title Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL (CLL-Frail)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors German CLL Study Group
Indications

chronic lymphocytic leukemia

Therapies

Acalabrutinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.